The epithelial barrier theory links the recent rise in chronic non-communicable diseases,
notably autoimmune and allergic disorders, to environmental agents disrupting the epithelial …

Recent research indicates that the microbiome has a significant impact on the progression of
inflammatory bowel disease (IBD) and that creating therapies that change its composition …

Purpose The prevalence of inflammatory bowel disease (IBD) is on the rise worldwide. We
utilizes data from the Global Burden of Diseases (GBD) 2021 to analyze the national-level …

Epidemiological and preclinical studies have indicated a factual association between gut
microbiota dysbiosis and high incidence of colitis. Dietary polysaccharides can specifically …

Gut microbiota dysbiosis has a critical role in the pathogenesis of inflammatory bowel
diseases, prompting the exploration of novel therapeutic approaches like fecal microbiota …

Background Intestinal barrier dysfunction is a significant contributor to the recurrence and
refractory of ulcerative colitis (UC). Promoting the interaction between group 3 innate …

Lactobacillus delbrueckii subsp. lactis CIDCA 133 is a health-promoting bacterium that can
alleviate gut inflammation and improve the epithelial barrier in a mouse model of mucositis …

Objective To investigate the prevalence and risk factors of psychological symptoms and
quality of life (QoL) in early patients with inflammatory bowel disease (IBD). Methods From …

Latilactobacillus curvatus is a candidate probiotic that is known to have antioxidant,
immunomodulatory, anti-obesity, and colitis-relieving beneficial effects. Here, we evaluated …

The mammalian intestine is colonized by trillions of microorganisms that are collectively
referred to as the gut microbiota. The majority of symbionts have co-evolved with their host in …